Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Prognostication of patients with colorectal cancer (CRC) currently relies on tumor-node-metastasis (TNM) staging but clinical outcomes of patients of the same histoclinical stage are heterogeneous. It is therefore imperative to devise novel molecular tests to stratify CRC patients. | Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer